These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14743001)

  • 1. The role of complement receptors in production of antibodies specific for Galalpha1,3Gal.
    Kaye J; Bagley J; Malkowski D; Iacomini J
    Transplantation; 2004 Jan; 77(2):314-6. PubMed ID: 14743001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of natural antibody specificity on antigen immunogenicity.
    Benatuil L; Kaye J; Rich RF; Fishman JA; Green WR; Iacomini J
    Eur J Immunol; 2005 Sep; 35(9):2638-47. PubMed ID: 16082726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal.
    Cretin N; Bracy J; Hanson K; Iacomini J
    J Immunol; 2002 Feb; 168(3):1479-83. PubMed ID: 11801692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
    Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
    Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of B-cell tolerance by retroviral gene therapy.
    Bracy JL; Iacomini J
    Blood; 2000 Nov; 96(9):3008-15. PubMed ID: 11049978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
    Katopodis AG; Warner RG; Duthaler RO; Streiff MB; Bruelisauer A; Kretz O; Dorobek B; Persohn E; Andres H; Schweitzer A; Thoma G; Kinzy W; Quesniaux VF; Cozzi E; Davies HF; Mañez R; White D
    J Clin Invest; 2002 Dec; 110(12):1869-77. PubMed ID: 12488437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.
    Posekany KJ; Pittman HK; Swanson MS; Haisch CE; Verbanac KM
    Anticancer Res; 2004; 24(2B):605-12. PubMed ID: 15161001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.
    Unfer RC; Hellrung D; Link CJ
    Cancer Res; 2003 Mar; 63(5):987-93. PubMed ID: 12615713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of xenograft-competent genetically modified pig cells using a targeted toxin, isolectin BS-I-B4 conjugate.
    Akasaka E; Watanabe S; Himaki T; Ohtsuka M; Yoshida M; Miyoshi K; Sato M
    Xenotransplantation; 2010; 17(1):81-9. PubMed ID: 20149191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs.
    Puga Yung GL; Li Y; Borsig L; Millard AL; Karpova MB; Zhou D; Seebach JD
    Xenotransplantation; 2012; 19(3):196-206. PubMed ID: 22702471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of anti-alphaGalactosyl antibodies predict survival and peritoneal dialysis-related enteric peritonitis rates in patients undergoing renal replacement therapy.
    Fontán MP; Máñez R; Rodríguez-Carmona A; Peteiro J; Martínez V; García-Falcón T; Domenech N
    Am J Kidney Dis; 2006 Dec; 48(6):972-82. PubMed ID: 17162152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
    Larkin JM; Porter CD
    Cancer Immunol Immunother; 2007 Jan; 56(1):60-9. PubMed ID: 16715304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.
    Larkin JM; Norsworthy PJ; A'Hern RP; Eisen TG; Gore ME; Porter CD
    Melanoma Res; 2006 Apr; 16(2):157-63. PubMed ID: 16567971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
    Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
    Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin heavy chain transgenic mice expressing Galalpha(1,3)Gal-reactive antibodies.
    Cretin N; Iacomini J
    Transplantation; 2002 May; 73(10):1558-64. PubMed ID: 12042640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies.
    Rieben R; Bovin NV; Korchagina EY; Oriol R; Nifant'ev NE; Tsvetkov DE; Daha MR; Mohacsi PJ; Joziasse DH
    Glycobiology; 2000 Feb; 10(2):141-8. PubMed ID: 10642605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of human pancreatic cancer cell tumorigenicity by alpha1,3galactosyltransferase gene transfer.
    Aubert M; Crotte C; Bernard JP; Lombardo D; Sadoulet MO; Mas E
    Int J Cancer; 2003 Dec; 107(6):910-8. PubMed ID: 14601050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
    Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
    Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current cellular innate immune hurdles in pig-to-primate xenotransplantation.
    Schneider MK; Seebach JD
    Curr Opin Organ Transplant; 2008 Apr; 13(2):171-7. PubMed ID: 18685299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.